Heart-on-a-chip systems: disease modeling and drug screening applications
Authors:
Open Access
- 6 February 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (5) , 1494-1528
Abstract
Heart-on-chip systems are one of the tools at the forefront in the race to develop alternative in vitro preclinical testing for disease modeling, drug toxicity and efficacy assessment. Further innovation and standardization will accelerate their use.Keywords
Funding Information
- National Institute of Standards and Technology
This publication has 406 references indexed in Scilit:
- The Effect of Preoperative Melatonin on Nuclear Erythroid 2-Related Factor 2 Activation in Patients Undergoing Coronary Artery Bypass Grafting SurgeryOxidative Medicine and Cellular Longevity, 2013
- The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cellsBiomaterials, 2013
- Increased afterload induces pathological cardiac hypertrophy: a new in vitro modelBasic Research in Cardiology, 2012
- RBM20, a gene for hereditary cardiomyopathy, regulates titin splicingNature Medicine, 2012
- First Evidence of Depressed Contractility in the Border Zone of a Human Myocardial InfarctionThe Annals of Thoracic Surgery, 2012
- Friedreich's ataxia: Pathology, pathogenesis, and molecular geneticsJournal of the Neurological Sciences, 2011
- Solid phase extraction of DNA from biological samples in a post-based, high surface area poly(methyl methacrylate) (PMMA) microdeviceLab on a Chip, 2011
- Ischemia/reperfusion injury of primary porcine cardiomyocytes in a low-shear microfluidic culture and analysis deviceThe Analyst, 2011
- Fabrication of Microfluidic Reactors and Mixing Studies for Luciferase DetectionAnalytical Chemistry, 2008
- Drug administration in animal studies of cardiac arrest does not reflect human clinical experienceResuscitation, 2007